Correlation Between Walker Dunlop and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Walker Dunlop and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Walker Dunlop and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Vertex Pharmaceuticals.
Diversification Opportunities for Walker Dunlop and Vertex Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Walker and Vertex is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Walker Dunlop and Vertex Pharmaceuticals
Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 20.47 times less return on investment than Vertex Pharmaceuticals. In addition to that, Walker Dunlop is 1.64 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about 0.01 of its total potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.41 per unit of volatility. If you would invest 39,505 in Vertex Pharmaceuticals Incorporated on November 4, 2024 and sell it today you would earn a total of 5,010 from holding Vertex Pharmaceuticals Incorporated or generate 12.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 90.91% |
| Values | Daily Returns |
Walker Dunlop vs. Vertex Pharmaceuticals Incorpo
Performance |
| Timeline |
| Walker Dunlop |
| Vertex Pharmaceuticals |
Walker Dunlop and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Walker Dunlop and Vertex Pharmaceuticals
The main advantage of trading using opposite Walker Dunlop and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.| Walker Dunlop vs. Mr Cooper Group | Walker Dunlop vs. Velocity Financial Llc | Walker Dunlop vs. Security National Financial | Walker Dunlop vs. Encore Capital Group |
| Vertex Pharmaceuticals vs. UPDATE SOFTWARE | Vertex Pharmaceuticals vs. UNIVMUSIC GRPADR050 | Vertex Pharmaceuticals vs. UNIVERSAL MUSIC GROUP | Vertex Pharmaceuticals vs. Beta Systems Software |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |